Follow the 나이벡 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 나이벡 has recorded 25 reports. Market capitalisation: €218.5bn. The latest transaction was filed on 16 March 2026 (Other). Among the most active insiders: 정종평. Every trade is openly available.
25
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Fundamental score
Ranked 10,588 of 26,270 companies
56.9
score / 100
Value
37
Quality
77
FCF yld0.3%
Earn yld2.6%
EV/EBITDA22.1x
ROE19%
Gross mgn64%
Net mgn14%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.